Cherington Charles 4
4 · Eterna Therapeutics Inc. · Filed Apr 4, 2025
Insider Transaction Report
Form 4
Cherington Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-04-02$0.10/sh+3,768,397$394,174→ 20,401,602 total
Footnotes (2)
- [F1]On April 2, 2025, pursuant to a private placement offering by the Issuer, the reporting person acquired 3,768,397 shares of the Issuer's Common Stock.
- [F2]On December 3, 2024, the Issuer paid a dividend to all holders of record of its Series A Preferred Stock on such date of $0.05 per share of Series A Preferred Stock. Pursuant to the terms of the Series A Preferred Stock, the Issuer elected to pay the dividend in an equivalent amount of common stock. As a result, the Reporting Person received 5,082 shares of the Issuer's common stock.